Christine Mpundu-Kaambwa1, Gang Chen2, Elisabeth Huynh3, Remo Russo4,5, Julie Ratcliffe6,7. 1. Institute for Choice, University of South Australia Business School, Level 3 Way Lee Building, North Terrace, Adelaide, SA, 5001, Australia. christine.mpundu-kaambwa@unisa.edu.au. 2. Centre for Health Economics, Monash Business School, Monash University, Melbourne, Australia. 3. Department of Health Services Research and Policy, The Australian National University, Canberra, Australia. 4. Faculty of Health Sciences, School of Medicine, Flinders University, Adelaide, Australia. 5. Department of Paediatric Rehabilitation, Women's and Children's Hospital, Adelaide, Australia. 6. Institute for Choice, University of South Australia Business School, Level 3 Way Lee Building, North Terrace, Adelaide, SA, 5001, Australia. 7. Health and Social Care Economics Group, College of Nursing and Health Sciences, Flinders University, Adelaide, Australia.
Abstract
BACKGROUND: Mapping algorithms have been indicated as a second-best solution for estimating health state utilities for the calculation of quality-adjusted life-years within cost-utility analysis when no generic preference-based measure is incorporated into the study. However, the predictive performance of these algorithms may be variable and hence it is important to assess their external validity before application in different settings. OBJECTIVE: The aim of this study was to assess the external validity and generalisability of existing mapping algorithms for predicting preference-based Child Health Utility 9D (CHU9D) utilities from non-preference-based Pediatric Quality of Life Inventory (PedsQL) scores among children and adolescents living with or without disabilities or health conditions. METHODS: Five existing mapping algorithms, three developed using data from an Australian community population and two using data from a UK population with one or more self-reported health conditions, were externally validated on data from the Longitudinal Study of Australian Children (n = 6623). The predictive accuracy of each mapping algorithm was assessed using the mean absolute error (MAE) and the mean squared error (MSE). RESULTS: Values for the MAE (0.0741-0.2302) for all validations were within the range of published estimates. In general, across all ages, the algorithms amongst children and adolescents with disabilities/health conditions (Australia MAE: 0.2085-0.2302; UK MAE: 0.0854-0.1162) performed worse relative to those amongst children and adolescents without disabilities/health conditions (Australia MAE: 0.1424-0.1645; UK MAE: 0.0741-0.0931). CONCLUSIONS: The published mapping algorithms have acceptable predictive accuracy as measured by MAE and MSE. The findings of this study indicate that the choice of the most appropriate mapping algorithm to apply may vary according to the population under consideration.
BACKGROUND: Mapping algorithms have been indicated as a second-best solution for estimating health state utilities for the calculation of quality-adjusted life-years within cost-utility analysis when no generic preference-based measure is incorporated into the study. However, the predictive performance of these algorithms may be variable and hence it is important to assess their external validity before application in different settings. OBJECTIVE: The aim of this study was to assess the external validity and generalisability of existing mapping algorithms for predicting preference-based Child Health Utility 9D (CHU9D) utilities from non-preference-based Pediatric Quality of Life Inventory (PedsQL) scores among children and adolescents living with or without disabilities or health conditions. METHODS: Five existing mapping algorithms, three developed using data from an Australian community population and two using data from a UK population with one or more self-reported health conditions, were externally validated on data from the Longitudinal Study of Australian Children (n = 6623). The predictive accuracy of each mapping algorithm was assessed using the mean absolute error (MAE) and the mean squared error (MSE). RESULTS: Values for the MAE (0.0741-0.2302) for all validations were within the range of published estimates. In general, across all ages, the algorithms amongst children and adolescents with disabilities/health conditions (Australia MAE: 0.2085-0.2302; UK MAE: 0.0854-0.1162) performed worse relative to those amongst children and adolescents without disabilities/health conditions (Australia MAE: 0.1424-0.1645; UK MAE: 0.0741-0.0931). CONCLUSIONS: The published mapping algorithms have acceptable predictive accuracy as measured by MAE and MSE. The findings of this study indicate that the choice of the most appropriate mapping algorithm to apply may vary according to the population under consideration.
Authors: Ewout W Steyerberg; Sacha E Bleeker; Henriëtte A Moll; Diederick E Grobbee; Karel G M Moons Journal: J Clin Epidemiol Date: 2003-05 Impact factor: 6.437
Authors: Neil K Chadha; Jennifer Allegro; Michelle Barton; Michael Hawkes; Hayley Harlock; Paolo Campisi Journal: Otolaryngol Head Neck Surg Date: 2010-11 Impact factor: 3.497
Authors: Thomas P A Debray; Yvonne Vergouwe; Hendrik Koffijberg; Daan Nieboer; Ewout W Steyerberg; Karel G M Moons Journal: J Clin Epidemiol Date: 2014-08-30 Impact factor: 6.437
Authors: Tosin Lambe; Emma Frew; Natalie J Ives; Rebecca L Woolley; Carole Cummins; Elizabeth A Brettell; Emma N Barsoum; Nicholas J A Webb Journal: Pharmacoeconomics Date: 2018-04 Impact factor: 4.981
Authors: Mirella De Civita; Dean Regier; Abul H Alamgir; Aslam H Anis; Mark J Fitzgerald; Carlo A Marra Journal: Pharmacoeconomics Date: 2005 Impact factor: 4.981
Authors: Mark J Harrison; Mark Lunt; Suzanne M M Verstappen; Kath D Watson; Nick J Bansback; Deborah P M Symmons Journal: Health Qual Life Outcomes Date: 2010-02-11 Impact factor: 3.186